Pharmacological Targets for Pulmonary Vascular Disease: Vasodilation versus Anti-Remodelling
Author:
Publisher
Humana Press
Link
http://link.springer.com/content/pdf/10.1007/978-1-60761-500-2_31
Reference62 articles.
1. Colson P, Saussine M, Séguin JR, Cuchet D, Chaptal PA, Roquefeuil B (1992) Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 74:805-808
2. Narine L, Hague LK, Walker JH et al (2005) Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension. Curr Med Res Opin 21:2007-2016
3. Kenyon KW, Nappi JM (2003) Bosentan for the treatment of pulmonary arterial hypertension. Ann Pharmacother 37:1055-1062
4. Gilbert C, Brown MCJ, Cappelleri JC, Carlsson M, McKenna SP (2009) Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil. Chest 135:137-142
5. Teichert-Kuliszewska K, Kutryk MJB, Kuliszewski MA et al (2006) Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 98:209-217
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery–jugular vein shunt pulmonary hypertension rat model;Interactive CardioVascular and Thoracic Surgery;2017-05-04
2. 2-Aminoethyldiphenylborinate modifies the pulmonary circulation in pulmonary hypertensive newborn lambs partially gestated at high altitude;American Journal of Physiology-Lung Cellular and Molecular Physiology;2016-10-01
3. Lung Circulation;Comprehensive Physiology;2016-03-15
4. A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung;PLOS ONE;2015-08-28
5. Pulmonary Hypertension Is a Probable NO/ONOO− Cycle Disease: A Review;ISRN Hypertension;2013-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3